Skip to main content

Brevan Howard Capital Management LP

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1512857 ST. HELIER, Y9

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$965,740
+$785,927 QoQ
Shares Held
96,574
+411.3% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#123
of 316 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $20,713,489 across 26 Drug Manufacturers - Specialty & Generic names. BCRX ranks #8 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 BCRX
Biocryst Pharmaceuticals Inc
This page
96,574 $965,740

All Filings in BCRX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $965,740 96,574
2026-03-31 $179,813 18,888
2025-09-30 $2,472,784 325,795
2025-06-30 $1,239,203 138,304
2025-03-31 $405,164 54,022
2024-12-31 $425,962 56,644
2024-09-30 $603,956 79,468
2024-06-30 $583,806 94,467
2024-03-31 $63,494 12,499
2023-12-31 $419,845 70,091